Results 211 to 220 of about 10,746,438 (360)

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

New England Journal of Medicine, 2017
K. Ataga, A. Kutlar, J. Kanter, D. Liles, R. Cançado, J. Friedrisch, T. Guthrie, J. Knight-Madden, Ofelia A Alvarez, V. Gordeuk, S. Gualandro, M. P. Colella, Wally R. Smith, S. Rollins, J. Stocker, R. Rother   +15 more
semanticscholar   +1 more source

Suppression of RBC alloimmunization and regulation of CD4+T cell dependence by C3 is not due to genetic confounders in mice

Transfusion, EarlyView.
Abstract Background Activation of complement protein C3 generally enhances antibody responses and C3‐null mice have decreased antibody‐based immunity. Mener et al. have reported a paradoxical suppressor function for C3 in alloimmunization to transfused RBCs as alloantibodies are increased in C3‐null mice.
Arijita Jash, Ariel Hay, James C. Zimring   +2 more
wiley   +1 more source

Vitamin D deficiency in sickle cell disease: a neglected comorbidity in Tunisia. [PDF]

Ann Hematol
Othmani M, Amri Y, Jouini Y, Ouali F, Chelbi S, Hadj Fredj S, Dabboubi R, Messaoud T.   +7 more
europepmc   +1 more source

Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia

, 2006
Elizabeth C. Uong, Jessica H. Boyd, Michael R. DeBaun   +2 more
openalex   +2 more sources

Discordance between self-reported premarital and post-marital parental sickle cell status

, 2020
Eneh Chizoma
openalex   +2 more sources

Topical Vapocoolant-Associated Vaso-occlusive Event in a 10-year-old with Sickle Cell Disease

, 2021
Alekya Kothamasu, Matthew S. MacDougall, Jocelyn Mallard, Lewis L. Hsu   +3 more
openalex   +2 more sources

An audit of platelet transfusions at a tertiary care center: New opportunities for patient blood management with the 2025 AABB/ICTMG platelet guidelines

Transfusion, EarlyView.
Abstract Background Platelet transfusions are an important tool to prevent and stop bleeding. Thresholds for pretransfusion platelet counts have been studied in various patient populations, yielding evidence‐based guidelines. The Association for the Advancement of Blood and Biotherapies (AABB) collaborated with the International Collaboration for ...
Rylee Yakymi, Claudia S. Cohn
wiley   +1 more source

Cost‐effectiveness of a hypothetical assay to evaluate stored blood quality prior to transfusion

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Unsuccessful red blood cell (RBC) transfusion, necessitating unscheduled repeat transfusion, is common and costly. Several technologies have been developed to assess stored blood quality, but the potential cost‐effectiveness of pretransfusion testing versus no testing to prevent unscheduled re‐transfusion is unknown ...
Melissa C. Caughey, Tara Templin, Nareg H. Roubinian, Matthew S. Karafin   +3 more
wiley   +1 more source

Cellular therapies for sickle cell disease: Should we be calling them a cure? [PDF]

Hemasphere
Okoibhole LO, Dasaolu F, Garba-Sani Z, Hibbs SP.   +3 more
europepmc   +1 more source

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study

, 2021
Kadère Konté, Erfan Nur, Man Tang, Jarom Heijmans, Charlotte F.J. Van Tuijn, Bart J. Biemond   +5 more
openalex   +2 more sources